0 Comments
0 Shares
519 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
PCSK9 Inhibitors Market Driven by Cardiovascular Disease PrevalencePCSK9 inhibitors are a class of lipid-lowering biologics designed to target proprotein convertase subtilisin/kexin type 9, offering a potent reduction in low-density lipoprotein (LDL) cholesterol for patients at high cardiovascular risk. Administered via subcutaneous injection, these monoclonal antibodies and small molecules block PCSK9 interaction with LDL receptors, enhancing receptor...0 Comments 0 Shares 632 Views 0 Reviews